Corporate Profile

ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company. We design, develop and commercialize exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions to stand and walk again. ReWalk, our platform exoskeleton, combines our patented tilt-sensor technology with an on-board computer and motion sensors to drive motorized legs that power movement. We currently offer two products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal, designed for everyday use by individuals at home and in their communities, is the first exoskeleton to receive FDA clearance for personal use, and is custom fit for each user. ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides valuable exercise and therapy and enables individuals to evaluate their capacity for using ReWalk Personal in the future. ReWalk is a breakthrough technology that can fundamentally change the health and life experiences of users.
RWLK (Common Stock)
Stock chart for: RWLK.O.  Currently trading at $1.36 with a 52 week high of $7.85 and a 52 week low of $1.10.

Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases more

ReWalk Robotics to Report Second Quarter 2017 Financial Results on August 3, 2017 — 07/20/17
ReWalk Robotics Announces French Distribution Agreement with Harmonie Médical Service — 07/11/17
ReWalk Unveils Soft Suit Exoskeleton for Stroke Patients — 06/19/17

Events more

Q2 2017 ReWalk Robotics Ltd Earnings Conference Call
Thursday, August 3, 2017 8:30 a.m. ET